iRhythm Holdings (IRTC) FCF Margin Growth (3y) (2018 - 2026)

iRhythm Holdings (IRTC) FCF Margin Growth (3y) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (3y) (Qtr)
1 Abbott Laboratories 183.86 Bn 176.56 Bn 6.27 Bn 38.00
2 Stryker 128.65 Bn 125.78 Bn 3.81 Bn 30.00
3 Medtronic 108.75 Bn 99.53 Bn 6.41 Bn -310.00
4 Boston Scientific 68.34 Bn 66.89 Bn 3.61 Bn 96.00
5 Edwards Lifesciences 48.33 Bn 44.65 Bn 1.29 Bn -2,196.00
6 GE HealthCare Technologies 28.35 Bn 26.07 Bn 1.98 Bn -472.00
7 Dexcom 28.33 Bn 27.21 Bn 750.30 Mn 2,679.00
8 Smith & Nephew 26.90 Bn 26.32 Bn - -
9 Koninklijke Philips 25.45 Bn 22.33 Bn 2.07 Bn -20.00
10 iRhythm Holdings 3.69 Bn 3.14 Bn 141.35 Mn 2,104.00

Historic Data

Download Data
DateValue
Mar 31, 2026 2,104.00
Dec 31, 2025 -1,841.00
Sep 30, 2025 4,099.00
Jun 30, 2025 274.00
Mar 31, 2025 4,361.00
Dec 31, 2024 134.00
Sep 30, 2024 1,437.00
Jun 30, 2024 2,340.00
Mar 31, 2024 1,050.00
Dec 31, 2023 -3,610.00
Sep 30, 2023 428.00
Jun 30, 2023 1,925.00
Mar 31, 2023 320.00
Dec 31, 2022 7,005.00
Sep 30, 2022 -1,063.00
Jun 30, 2022 65.00
Mar 31, 2022 -1,186.00
Dec 31, 2021 2,328.00
Sep 30, 2021 1,175.00
Jun 30, 2021 1,331.00